Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Last Updated: May 27, 2022

Rubicon Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for RUBICON, and what generic and branded alternatives to RUBICON drugs are available?

RUBICON has thirty-eight approved drugs.

Summary for Rubicon

US Patents:	0
Tradenames:	35
Ingredients:	35
NDAs:	38

Drugs and US Patents for Rubicon

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try it Free
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Rubicon	OXYBUTYNIN CHLORIDE	oxybutynin chloride	TABLET, EXTENDED RELEASE;ORAL	214415-002	Oct 27, 2020	AB	RX	No	No		See Plans and Pricing				See Plans and Pricing
Rubicon	METOPROLOL TARTRATE	metoprolol tartrate	TABLET;ORAL	200981-004	Aug 21, 2019	AB	RX	No	No		See Plans and Pricing				See Plans and Pricing
Rubicon	AMIODARONE HYDROCHLORIDE	amiodarone hydrochloride	TABLET;ORAL	078578-003	Feb 26, 2021	AB	RX	No	No		See Plans and Pricing				See Plans and Pricing
Rubicon	OXYBUTYNIN CHLORIDE	oxybutynin chloride	TABLET, EXTENDED RELEASE;ORAL	214415-003	Oct 27, 2020	AB	RX	No	No		See Plans and Pricing				See Plans and Pricing
Rubicon	LABETALOL HYDROCHLORIDE	labetalol hydrochloride	TABLET;ORAL	211953-002	Aug 18, 2021	AB	RX	No	No		See Plans and Pricing				See Plans and Pricing
Rubicon	ACETAZOLAMIDE	acetazolamide	TABLET;ORAL	215101-002	Aug 19, 2021	AB	RX	No	No		See Plans and Pricing				See Plans and Pricing
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Rubicon

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt

Johnson and Johnson

Colorcon

Baxter

McKinsey

McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.